These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 949879)

  • 21. Effect of aspirin on the complement system in vitro.
    Hänsch GM; Voigtländer V; Rother U
    Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    Wager O
    Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: Systemic lupus erythematosus and rheumatoid arthritis.
    Hughes GR
    J Clin Pathol; 1976 Jan; 29(1):84. PubMed ID: 1249256
    [No Abstract]   [Full Text] [Related]  

  • 24. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1.
    Thielens NM; Villiers MB; Reboul A; Villiers CL; Colomb MG
    FEBS Lett; 1982 May; 141(1):19-24. PubMed ID: 6282646
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states.
    Agnello V
    Arthritis Rheum; 1978 Jun; 21(5 Suppl):S146-52. PubMed ID: 666879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunoglobulins and complement in systemic lupus erythematosus, rheumatoid arthritis and juvenile rheumatoid arthritis].
    Dostal Ts; Shusta A; Gana I; Bardfeld R
    Ter Arkh; 1974; 46(11):98-100. PubMed ID: 4216106
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.
    Hedberg H; Lundh B; Laurell AB
    Clin Exp Immunol; 1970 May; 6(5):707-12. PubMed ID: 5477926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of synovial fluid total hemolytic complement activity.
    Kim HJ; McCarty DJ; Kozin F; Koethe S
    J Rheumatol; 1980; 7(2):143-52. PubMed ID: 7373616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of RHP and of unbound C1q in rheumatoid arthritis and systemic lupus erythematosus.
    Rosano CL; Parhami N; Hechemy KE; Hurwitz C
    Inflammation; 1988 Aug; 12(4):351-60. PubMed ID: 3262584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement and the clinician.
    Palmer DG
    Aust N Z J Med; 1976 Aug; 6(4):349-56. PubMed ID: 1070993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dynamics of the immunological changes in rheumatoid arthritis borderline with systemic lupus erythematosus].
    Nasonova VA; Speranskiĭ AI; Astapanko MG; Bulanova TD
    Vopr Revm; 1978; (1):7-11. PubMed ID: 654199
    [No Abstract]   [Full Text] [Related]  

  • 33. Activation of complement in human nephritis.
    Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
    Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies with human leukocyte lysosomes. Evidence for antilysosome antibodies in lupus erythematosus and for the presence of lysosomal antigen in inflammatory diseases.
    Bell DA; Thiem PA; Vaughan JH; Leddy JP
    J Clin Invest; 1975 Feb; 55(2):256-68. PubMed ID: 1092714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appraisal of rheumatoid arthritis as an immune complex disease.
    Broder I; Urowitz MB; Gordon DA
    Med Clin North Am; 1972 Mar; 56(2):529-39. PubMed ID: 4111877
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-nuclear factors in rheumatoid arthritis, systemic lupus erythematosus and other diseases. Re-evaluation of the nucleoprotein complement fixation technique and anti-complementary activity.
    Onodera S; Schubart AF; Ewald RW; Heuckenkamp PU
    J Chronic Dis; 1966; 19(11):1133-44. PubMed ID: 5297998
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunoglobulin and complement deposits in lupus glomerulonephritis.
    Méry JP; Morel-Maroger L; Boelaert J
    Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
    [No Abstract]   [Full Text] [Related]  

  • 38. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system.
    Nakamura S; Yoshinari M; Saku Y; Hirakawa K; Miishima C; Murai K; Tokiyama K; Fujishima M
    Ann Rheum Dis; 1991 Oct; 50(10):713-6. PubMed ID: 1958096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited complement deficiency states and SLE.
    Rynes RI
    Clin Rheum Dis; 1982 Apr; 8(1):29-47. PubMed ID: 6288318
    [No Abstract]   [Full Text] [Related]  

  • 40. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
    Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
    J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.